Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...
Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new ...
Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...
Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...
Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...
Nita Ambani recently revealed about the obesity struggles that Anant Ambani deals. The conversation they had before his ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
4d
News Medical on MSNDoes obesity affect intelligence? Study finds the answer hasn't changedA decades-long study of Danish conscripts finds that despite the rise in obesity, the inverse relationship between intelligence and BMI has remained unchanged.
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...
The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results